- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 8 x CLR: CHOLESTEROL(Non-covalent)
- 6 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
3PE.2: 23 residues within 4Å:- Chain A: L.278, F.281, L.282, L.285, T.289, L.305, N.306, S.309, N.310, L.311, L.323, Y.352, M.355, F.358, L.359, K.369, S.370, W.373, L.374, W.395, L.400, I.406, L.410
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:L.278, A:F.281, A:L.282, A:L.323, A:Y.352, A:Y.352, A:M.355, A:F.358, A:L.359, A:L.359, A:W.373, A:L.374, A:W.395, A:W.395, A:L.400, A:I.406, A:L.410
- Hydrogen bonds: A:K.369
- Salt bridges: A:H.299
3PE.3: 19 residues within 4Å:- Chain A: I.243, L.247, T.250, K.258, L.326, L.329, L.332, A.333, F.336, P.338, A.350, L.351, F.354
- Chain B: V.246, I.249, T.250, F.257
- Ligands: CLR.5, 3PE.13
17 PLIP interactions:12 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:I.243, A:L.247, A:T.250, A:L.326, A:L.329, A:L.332, A:F.336, A:A.350, A:F.354, B:V.246, B:I.249, B:I.249, B:T.250, B:F.257
- Salt bridges: A:K.258, A:K.258, A:K.258
3PE.6: 18 residues within 4Å:- Chain A: Q.227, P.228, A.229, T.234, V.237, C.241, F.244, I.245, N.248, F.283, I.287, Y.290, H.313, Q.314, F.317
- Chain B: A.231, W.232, F.235
14 PLIP interactions:12 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.244, A:I.245, A:N.248, A:F.283, A:I.287, A:Y.290, A:Y.290, A:Y.290, B:W.232, B:F.235
- Hydrogen bonds: A:Q.227, A:A.229, A:Q.314
- Salt bridges: A:H.313
3PE.12: 28 residues within 4Å:- Chain B: L.278, F.281, L.282, L.285, T.289, F.303, L.305, N.306, S.309, N.310, L.311, L.316, I.319, L.323, Y.352, M.355, F.358, L.359, K.369, S.370, W.373, L.374, W.395, L.396, L.400, L.403, I.406, L.410
23 PLIP interactions:23 interactions with chain B- Hydrophobic interactions: B:L.278, B:F.281, B:L.282, B:F.303, B:I.319, B:L.323, B:Y.352, B:Y.352, B:M.355, B:F.358, B:L.359, B:W.373, B:L.374, B:L.374, B:W.395, B:W.395, B:L.396, B:L.400, B:L.403, B:I.406, B:L.410
- Hydrogen bonds: B:N.306, B:N.306
3PE.13: 19 residues within 4Å:- Chain A: V.246, T.250, L.253, F.257
- Chain B: I.243, L.247, T.250, K.258, L.326, L.329, L.332, A.333, F.336, P.338, Y.347, F.354
- Ligands: 3PE.3, CLR.14, PLM.17
14 PLIP interactions:10 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:I.243, B:T.250, B:L.326, B:L.332, B:F.336, B:Y.347, B:F.354, A:V.246, A:V.246, A:L.253, A:F.257
- Salt bridges: B:K.258, B:K.258, B:K.258
3PE.15: 16 residues within 4Å:- Chain A: A.231, W.232, F.235
- Chain B: A.229, C.241, F.244, I.245, N.248, I.249, F.283, I.287, Y.290, R.293, H.313, Q.314, F.317
17 PLIP interactions:15 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:F.244, B:I.245, B:N.248, B:I.249, B:F.283, B:F.283, B:I.287, B:Y.290, B:Y.290, B:F.317, B:F.317, A:W.232, A:F.235
- Hydrogen bonds: B:A.229, B:R.293, B:Q.314
- Salt bridges: B:H.313
- 2 x PLM: PALMITIC ACID(Non-covalent)
PLM.9: 5 residues within 4Å:- Chain A: W.232, T.233, F.235, R.236
- Chain B: I.245
7 PLIP interactions:6 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:W.232, A:W.232, A:W.232, A:F.235, B:I.245
- Hydrogen bonds: A:T.233
- Salt bridges: A:R.236
PLM.17: 5 residues within 4Å:- Chain A: I.245
- Chain B: W.232, F.235, R.236
- Ligands: 3PE.13
4 PLIP interactions:1 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:I.245, B:W.232, B:F.235
- Salt bridges: B:R.236
- 2 x ACD: ARACHIDONIC ACID(Non-covalent)
ACD.10: 7 residues within 4Å:- Chain A: S.264, I.265, W.266, H.587, I.591, P.598, L.599
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.265, A:I.265, A:I.591, A:L.599
- Salt bridges: A:H.587
ACD.18: 6 residues within 4Å:- Chain B: T.261, R.263, I.265, I.591, P.598, L.599
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:I.265, B:I.591, B:P.598, B:L.599
- Salt bridges: B:H.587
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zuo, P. et al., Synergistic activation of the human phosphate exporter XPR1 by KIDINS220 and inositol pyrophosphate. Nat Commun (2025)
- Release Date
- 2025-04-02
- Peptides
- Solute carrier family 53 member 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 8 x CLR: CHOLESTEROL(Non-covalent)
- 6 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
- 2 x PLM: PALMITIC ACID(Non-covalent)
- 2 x ACD: ARACHIDONIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zuo, P. et al., Synergistic activation of the human phosphate exporter XPR1 by KIDINS220 and inositol pyrophosphate. Nat Commun (2025)
- Release Date
- 2025-04-02
- Peptides
- Solute carrier family 53 member 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.